Mohindra v. Boghara

District Court, D. Arizona·Decided June 26, 2025·No. 2:25-cv-02050·Unknown

Opinion

WO

Raghav Mohindra, No. CV-25-02050-PHX-SHD

Plaintiff, ORDER

v.

Haresh Boghara, et al.,

Defendants. Pending before the Court are Plaintiff Raghav Mohindra’s Motion for Temporary Restraining Order (“TRO”) with Notice and Preliminary Injunction, and Epic Medical Services AZ LLC’s (“Epic AZ”) Motion to Intervene. (Docs. 8, 16.) Dr. Mohindra claims that Defendant Haresh Boghara fraudulently transferred funds from Epic AZ, over which Dr. Boghara has control, to himself and Defendant Christopher Kelly to avoid paying an arbitration award Dr. Mohindra obtained against Epic AZ (the “Award”). Because Dr. Mohindra has, at this early stage of the case, raised serious questions as to whether Dr. Boghara intends to or already has fraudulently transferred funds from Epic AZ to avoid payment on the Award, the Court grants Dr. Boghara temporary relief in the form of a 21- day TRO to maintain the status quo while the Court awaits further briefing from the parties and holds a hearing to determine whether a preliminary injunction is appropriate. The Court also orders expedited briefing on Epic AZ’s Motion to Intervene. The Court will hold a hearing on both motions on July 17, 2025, and invites briefing on the need for expedited discovery in advance of the hearing. I. BACKGROUND1 Dr. Mohindra formed a medical practice, More MD, in 2011. (Doc. 1 ¶ 14.) In 2021, Dr. Boghara offered to purchase a portion of Dr. Mohindra’s interest in More MD. (Id. ¶ 17.) Dr. Boghara then formed Epic AZ to purchase More MD’s assets. (Id. ¶ 19.) He was and is the sole member of Epic AZ. (Doc. 8 at 4.) In December 2021, Dr. Mohindra entered into a Membership Interest Purchase Agreement (“MIPA”) with Epic AZ, under which “Epic AZ agreed to purchase all of [Dr. Mohindra’s] membership interests in More MD for $10 million.” (Doc. 1 ¶¶ 24–25.) As part of the payment plan, Epic AZ was required to pay an “EBITDA Earn-Out”—a specific amount calculated using More MD’s yearly EBITDA—in 2023 and 2024. (Id. ¶¶ 25–26.) In spring 2023, “a dispute arose between [Dr. Mohindra], on the one hand, and [Dr. Boghara], Epic AZ, and several other entities owned and operated by Dr. Boghara, on the other hand, relating to the EBITDA Earn-Out payment owed to [Dr. Mohindra] under the MIPA.” (Doc. 8 at 5.) Dr. Mohindra instituted arbitration proceedings to resolve this dispute in August 2023. (Doc. 1 ¶ 32.) In May 2025, the arbitration panel ultimately issued a final arbitration award in Dr. Mohindra’s favor, including approximately $6 million for the EBITDA Earn-Out under the MIPA. (Doc. 8 at 6.) “As of June 19, 2025, the total amount due” to Dr. Mohindra under the final arbitration award is $6,816,354.39. (Id. at 8.) While the arbitration proceedings were ongoing, in March 2025, Dr. Mohindra learned Dr. Boghara had sold Epic AZ to Optima Medical (“Optima”) for $7 million (the “Optima Sales Proceeds” or “Proceeds”)—Optima, however, did not assume Epic AZ’s liabilities. (Id. at 6–7.) Dr. Mohindra requested emergency relief from the arbitration panel “to ensure that [Dr. Boghara] did not dissipate the funds from the sale.” (Id. at 7.) Dr. Boghara’s counsel represented to the arbitration panel that Dr. Boghara was not taking any actions to avoid paying what he owed to Dr. Mohindra and he had “no intent to avoid 1 These facts are supported by declarations and exhibits attached to Plaintiff’s Complaint and Motion, (see Docs. 1-1, 1-2, 1-3, 1-4; Docs. 8-1, 8-2), as well as documents filed by Defendant, (see Doc. 15-1). payment of a just award.” (Id. (emphasis omitted).) Dr. Boghara’s counsel offered to place $856,435 in escrow, which was an undisputed portion of the EBITDA Earn-Out award, and the arbitration panel encouraged Dr. Boghara to do so. (Doc. 8-2 at 79.) The panel, however, declined to provide additional relief. (Id.) On May 16, 2025, Epic AZ’s bankruptcy counsel sent correspondence to Dr. Mohindra’s counsel confirming that Epic AZ sold its assets to Optima for $7 million. (Id. at 94.) Bankruptcy counsel stated that, “[w]ithout any material assets left from the sale, [Epic AZ] obviously [could not] satisfy the Award in full in addition to its various other liabilities.” (Id.) To explain what had happened to the Optima Sales Proceeds, counsel stated that Epic AZ “only has $97,879 in funds under its direct control. In addition, Mike Novotny has escrowed $856,435 of funds on behalf of Epic. The remaining funds have been distributed to Dr. Haresh Boghara and Christopher Kelly.” (Id. (emphasis added).) Specifically, Epic AZ transferred $280,000 to Kelly (Dr. Boghara’s former counsel), “which [Kelly] assert[ed] represents fair compensation for services provided to Epic,” (id.), and distributed the remaining funds (approximately $6.72 million) to Dr. Boghara. (Id.; Doc. 8 at 8.) Shortly after sending this letter, Dr. Boghara paid Dr. Mohindra the $856,435 that had been escrowed. (Doc. 8-1 at 6 ¶ 32.) On June 11, 2025, Dr. Mohindra filed this suit, alleging fraudulent transfer of the Proceeds based on the information provided by Epic Az’s bankruptcy counsel. (Doc. 1.) On June 13, 2025, Dr. Mohindra’s counsel contacted Dr. Boghara’s counsel and Kelly to request they place the Optimal Sales Proceeds in escrow while the parties litigated this action. (Doc. 8 at 8.) “[Dr. Boghara’s] counsel declined,” and “Kelly did not respond at all.” (Id.) Dr. Mohindra then moved for a TRO and preliminary injunction (the “Motion”) on June 19, 2025. (Id. at 1.) On the Court’s order, Dr. Mohindra served Dr. Boghara and Kelly with a copy of the Motion on June 20, 2025. (Doc. 12 at 2; see also Doc. 11 at 2 n.1.) The following business day, Dr. Boghara filed an initial response opposing the Motion asserting, among other things, that the Proceeds had never been transferred and instead were sequestered in an Epic AZ account. (Doc. 11 at 3 (asserting that “no transfer has occurred, let alone a fraudulent one”).) The Court held a hearing on June 24, 2025, to allow both parties to present their initial positions.2 (Doc. 13.) After the hearing, the Court ordered Dr. Boghara to file a bank account statement “identifying (1) the financial institution where the Optima Sales Proceeds are currently being held, (2) the owner of the account, (3) the amount of the Optima Sales Proceeds in the account, and (4) all transactions involving the Optima Sales Proceeds for the last thirty (30) days.” (Doc. 14.) Dr. Boghara filed a notice along with two exhibits. (Doc. 15.) Exhibit 1 is a statement from Bank of America providing information about an account owned by “Aavema Partners LP” from May 1 through May 31, 2025, showing an ending total market value of $5,807,303.21. (Doc. 15-1 at 2–11.) Dr. Boghara is listed as the contact for the account, which appears to have been opened on April 21, 2025, with funds deposited on April 22, 2025. (Id.) Exhibit 2 is a letter from PlainsCapital Bank stating that Epic AZ has accounts with it and confirming that these accounts have a total balance of $5,863,565 spread across “Business Basics Checking,” “Business Money Market,” and “Business CD” accounts as of June 24, 2025, representing the remaining net proceeds from the Optima sale.3 (Id. at 13; Doc. 16 at 4 ¶ 7.) A plaintiff seeking a TRO must establish that (1) he is “likely to succeed on the merits”; (2) he is “likely to suffer irreparable harm in the absence of preliminary relief”; (3) “the balance of equities tips in [his] favor”; and (4) “an injunction is in the public interest.” Winter v. Nat. Res. Def. Council, Inc., 555 U.S. 7, 22 (2008); see also All. for the Wild Rockies v. Cottrell, 632 F.3d 1127, 1132 (9th Cir. 2011) (holding that, in the Ninth Circuit, “serious questions going to the merits and a hardship balance that tips sharply tow

Free access — add to your briefcase to read the full text and ask questions with AI

Mohindra v. Boghara, (D. Ariz. 2025).

Mohindra v. Boghara (Mohindra v. Boghara) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related